Morgan Stanley missed Q3 but posted record wealth flows. At $181.50, down 21% in three months, 13 times 2027 profit is too low for durable fees and buybacks.
Key points
- $232 billion of net new assets in Q3 2026 set a record and lifted client assets to $8.4 trillion.
- $3.03 a share in Q3 2026 missed estimates by 4% as September volumes slowed and carry reversed.
- 14.9% core capital ratio in Q3 2026 leaves 3.1 points of excess above the floor for buybacks.
The call
The market sees a cooldown. At $181.50 the stock costs about 13 times my 2027 profit estimate. That asks for almost no growth from trading and wealth. With the stock down 21% in three months, fear of a September repeat sets the bar low.
Quarterly profit dipped but stays above last yearCompany releases Jan 2025 to Oct 2026; Q4 FY26E is my forecast.
I see durable fees instead. Wealth added record flows that compound into advice revenue next year. Bank funding help in 2027 and a steady deal pipeline support my above price profit view. That gap plus a 2.5% dividend yield drives the buy.
Valuation
| Driver | Estimate |
|---|
| 2026 profit | $12.82 a share |
| 2027 profit | $13.70 a share |
| Target multiple | 16 times |
| Dividend next 12 months | $4.60 a share |
| Target in Oct 2027 | $219.20 a share |
Wealth now almost matches trading and bankingExhibit 99.1 and supplement, quarter ended Sep 30 2026.
A 16 times multiple fits 22.6% returns on tangible equity and recurring wealth fees. Upside of 20.8% plus yield offers strong asymmetry for a bank with excess capital.
Risks
- Trading and advisory slump if September weakness lasts, seen in lower cash volumes and stalled pipelines.
- IPO assets leave after lockups without converting to advice, seen in weak fee-based flows next two quarters.
- Deposit costs stay high and NII misses Q4 guide, seen in sweep outflows and higher funding rates.
What would change my mind
I would turn neutral if record assets stop converting into fee revenue while trading normalizes faster than expected.